Berberine
Showing 51 - 75 of 100
Type 2 Diabetes Trial in Xi'an (Bifidobacterium viable pharmaceutics, Berberine Hydrochloride)
Withdrawn
- Type 2 Diabetes Mellitus
- Bifidobacterium viable pharmaceutics
- Berberine Hydrochloride
-
Xi'an, Shaanxi, China
- +3 more
Nov 11, 2018
Helicobacter Pylori Infection Trial in China (Amoxicillin, Tetracycline tid, Tetracycline qid)
Not yet recruiting
- Helicobacter Pylori Infection
- Amoxicillin
- +5 more
-
Zhengzhou, Henan, China
- +5 more
Jun 28, 2022
Locally Advanced Cervical Cancer Trial in Mexico City (Curcumin, Curcumin + Piperine)
Recruiting
- Locally Advanced Cervical Cancer
- Curcumin
- Curcumin + Piperine
-
Mexico City, MexicoInstituto Nacional de Cancerología
Oct 6, 2023
Chinese Herbal Medicine in Alzheimer's Disease
Completed
- Alzheimer Disease
- GRAPE granules
-
Beijing, ChinaDongzhimen Hospital
Aug 18, 2021
Schizophrenia, Therapeutics Trial (Berberine, atypical antipsychotic, )
Completed
- Schizophrenia
- Therapeutics
- Berberine
- +2 more
- (no location specified)
May 24, 2018
Metabolic Syndrome, Female, Schizophrenia Trial in Tianjin (berberine)
Completed
- Metabolic Syndrome
- +2 more
- berberine
-
Tianjin, Tianjin, ChinaTianjin Anding Hospital
Apr 24, 2018
Schizophrenia Trial in Tianjin (Berberine, Placebo)
Completed
- Schizophrenia
- Berberine
- Placebo
-
Tianjin, Tianjin, ChinaTianjin Anding Hospital
May 13, 2018
Small Intestinal Bacterial Overgrowth Trial in Oxford (Novel Supplement Based Therapy)
Withdrawn
- Small Intestinal Bacterial Overgrowth
- Novel Supplement Based Therapy
-
Oxford, OhioGood Medicine
Jan 11, 2021
Lung Adenocarcinoma, EGFR Mutation Trial in Fuzhou (gefitinib, Berberine)
Unknown status
- Lung Adenocarcinoma
- EGFR Mutation
- gefitinib
- Berberine
-
Fuzhou, Fujian, ChinaFujian cancer hospital
Mar 31, 2018
Interaction Drug Food Trial in Spokane (goldenseal, Metformin, Furosemide)
Completed
- Interaction Drug Food
- goldenseal
- +4 more
-
Spokane, WashingtonWashington State University
May 22, 2020
Hypertension Trial in London (Limitless)
Recruiting
- Hypertension
- Limitless
-
London, Ontario, CanadaKGK Science Inc.
Mar 17, 2022
Breast Cancer, Colorectal Cancer, Cancer of Ovary Trial in Taichung (Cases for patients diagnosed with breast cancer,
Recruiting
- Breast Cancer
- +3 more
- Cases for patients diagnosed with breast cancer, colonrectal cancer, ovarian cancer and endometrial cancer
-
Taichung, TaiwanChina Medical University Hospital
Aug 3, 2021
Dyslipidemia Trial in Pavia (Nutraceutical, Control)
Completed
- Dyslipidemia
- Nutraceutical
- Control
-
Pavia, ItalyFondazione IRCCS Policlinico San Matteo
Jan 12, 2018
Hypercholesterolemia, Endothelial Dysfunction Trial in Naples (LopiGLIK™ therapy, Armolipid Plus® therapy)
Completed
- Hypercholesterolemia
- Endothelial Dysfunction
- LopiGLIK™ therapy
- Armolipid Plus® therapy
-
Naples, ItalyUniversity of Naples "Federico II"
Feb 14, 2019
Covid19 Trial (Ivermectin 0.6mg/kg/day, Ivermectin 1.0mg/kg/day, Placebo)
Not yet recruiting
- Covid19
- Ivermectin 0.6mg/kg/day
- +3 more
- (no location specified)
Jan 14, 2021
Metabolic Syndrome Trial in Timisoara, Timisoara (Daily administration: 2 tablets FaseMETS a day)
Completed
- Metabolic Syndrome
- Daily administration: 2 tablets FaseMETS a day
-
Timisoara, Timis, Romania
- +1 more
Sep 30, 2019
Burns Trial in Zagazig (Moist Exposed Burn Ointment (MEBO), Zagazig)
Unknown status
- Burns
- Moist Exposed Burn Ointment (MEBO)
- Zagazig
-
Zagazig, Alsharkia, EgyptZagazig University Hospitals
Jan 25, 2019
Gastritis, Peptic Ulcer, Dyspepsia Trial in Xi'an (Berberine, clarithromycin, Bismuth)
Completed
- Gastritis
- +2 more
- Berberine
- +4 more
-
Xi'an, Shanxi, China
- +1 more
Jan 15, 2017
Hypercholesterolemia, Inflammation, Atherosclerosis Trial (Nutraceutical combination (NC), No nutraceutical combination (noNC))
Completed
- Hypercholesterolemia
- +2 more
- Nutraceutical combination (NC)
- No nutraceutical combination (noNC)
- (no location specified)
Mar 21, 2018
Cardiovascular Risk Factors Trial in Naples (Placebo, Prescribed Diet, LopiGLIK®)
Completed
- Cardiovascular Risk Factors
- Placebo
- +3 more
-
Naples, ItalyFederico II University
Jul 29, 2019
Ulcerative Colitis Trial (berberine, regular treatment)
Unknown status
- Ulcerative Colitis
- berberine
- regular treatment
- (no location specified)
Nov 10, 2016
Graft Pain, Gingival Recession Trial (MEBO ointment, Hyaluronic Acid gel)
Unknown status
- Graft Pain
- Gingival Recession
- MEBO ointment
- Hyaluronic Acid gel
- (no location specified)
Nov 1, 2018
Metastatic Cancer Trial in Hangzhou (Non Chemotherapy, Chemotherapy and target therapy, Chinese herb medicine)
Unknown status
- Metastatic Cancer
- Non Chemotherapy
- +2 more
-
Hangzhou, Zhejiang, ChinaSir Run Run Shaw Hospital, affiliated with Zhejiang University S
Feb 12, 2019